Cargando…
Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability
INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection is associated with a clear prothrombotic phenotype. Although the exact pathophysiological mechanisms are not yet fully understood, thrombosis is clearly a highly important in the prognosis and outcome of COVID-19. As...
Autores principales: | van de Berg, Tom W., Hulshof, Anne-Marije M., Nagy, Magdolna, van Oerle, Rene, Sels, Jan-Willem, van Bussel, Bas, ten Cate, Hugo, Henskens, Yvonne, Spronk, Henri M.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903905/ https://www.ncbi.nlm.nih.gov/pubmed/33662799 http://dx.doi.org/10.1016/j.thromres.2021.02.026 |
Ejemplares similares
-
Differential Fibrinolysis Profile in COVID-19 Patients Dependent on Immunosuppressive Treatment Regimen: A Nested Case-Control Study
por: Nagy, Magdolna, et al.
Publicado: (2022) -
Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation
por: Hulshof, Anne-Marije, et al.
Publicado: (2021) -
Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort
por: van de Berg, Tom W., et al.
Publicado: (2022) -
The hypercoagulable profile of patients with stent thrombosis
por: Loeffen, R, et al.
Publicado: (2015) -
Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
por: Henskens, Yvonne M. C., et al.
Publicado: (2018)